Terconazole Suppository

Terconazole Suppository

Terconazole Suppository Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions


Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Terconazole Vaginal Suppositories, 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As this product is effective only for vulvovaginitis caused by the genus Candida, the diagnosis should be confirmed by KOH smears and/or cultures.


There is currently no drug history available for this drug.

Other Information

Terconazole Vaginal Suppositories, 80 mg are white to off-white suppositories for intravaginal administration, containing 80 mg of the antifungal agent terconazole, cis-1-[p-[[2-(2,4-Dichlorophenyl)-2- (1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4- isopropylpiperazine, in triglycerides derived from coconut and/or palm kernel oil (a base of hydrogenated vegetable oils) and butylated hydroxyanisole. The structural formula of terconazole is as follows:

Chemical Structure

Terconazole, a triazole derivative, is a white to almost white powder with a molecular weight of 532.47. It is insoluble in water; sparingly soluble in ethanol; and soluble in butanol.

Terconazole Suppository Manufacturers

  • Perrigo New York Inc
    Terconazole Suppository [Perrigo New York Inc]
  • Taro Pharmaceuticals U.s.a., Inc.
    Terconazole Suppository [Taro Pharmaceuticals U.s.a., Inc.]
  • G & W Laboratories, Inc.
    Terconazole Suppository [G & W Laboratories, Inc.]

Login To Your Free Account